Have a read of the latest Bionomics Now newletter, Clifford25. Nothing due in the immediate future but 101 Phase 1 initial readout 3Q 2017, 210 PTSD enrolment 1Q 2018.
If 210 proves up in the trials this will be a paradigm change in treatment of anxiety related disorders.I think we're finally coming towards the pointy end for this coy. Patience still required though.
